EG16349A - Novel organic compounds and their pharmaceutical use - Google Patents
Novel organic compounds and their pharmaceutical useInfo
- Publication number
- EG16349A EG16349A EG490/84A EG49084A EG16349A EG 16349 A EG16349 A EG 16349A EG 490/84 A EG490/84 A EG 490/84A EG 49084 A EG49084 A EG 49084A EG 16349 A EG16349 A EG 16349A
- Authority
- EG
- Egypt
- Prior art keywords
- organic compounds
- pharmaceutical use
- novel organic
- novel
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
- C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
- C07C17/2635—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving a phosphorus compound, e.g. Wittig synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
- C07C17/354—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction by hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
- C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
- C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838320943A GB8320943D0 (en) | 1983-08-03 | 1983-08-03 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EG16349A true EG16349A (en) | 1987-09-30 |
Family
ID=10546748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG490/84A EG16349A (en) | 1983-08-03 | 1984-08-01 | Novel organic compounds and their pharmaceutical use |
Country Status (28)
Country | Link |
---|---|
US (3) | US4665189A (es) |
EP (2) | EP0134111B1 (es) |
JP (1) | JPS6064954A (es) |
KR (1) | KR920005382B1 (es) |
AR (1) | AR240796A1 (es) |
AT (2) | ATE39110T1 (es) |
AU (1) | AU575575B2 (es) |
CA (2) | CA1297632C (es) |
CY (1) | CY1539A (es) |
DE (2) | DE3475516D1 (es) |
DK (1) | DK167008B1 (es) |
EG (1) | EG16349A (es) |
ES (1) | ES534825A0 (es) |
FI (1) | FI81084C (es) |
GB (2) | GB8320943D0 (es) |
GR (1) | GR80015B (es) |
HK (1) | HK51090A (es) |
HU (2) | HU199457B (es) |
IE (1) | IE57691B1 (es) |
IL (1) | IL72539A (es) |
MY (1) | MY102762A (es) |
NZ (1) | NZ209050A (es) |
PH (1) | PH21029A (es) |
PL (1) | PL144336B1 (es) |
PT (1) | PT79002B (es) |
SG (1) | SG28590G (es) |
SU (1) | SU1402256A3 (es) |
ZA (1) | ZA845923B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143931A (en) * | 1982-06-24 | 1992-09-01 | Smithkline Beecham Corporation | Leukotriene antagonists containing tetrazolyl groups |
AU573774B2 (en) * | 1984-02-02 | 1988-06-23 | Vanguard, Inc. | Sailboat traveler track |
GB8432144D0 (en) * | 1984-12-20 | 1985-01-30 | Lilly Industries Ltd | Organic compounds |
GB8502258D0 (en) * | 1985-01-30 | 1985-02-27 | Lilly Industries Ltd | Organic compounds |
US4937253A (en) * | 1985-04-19 | 1990-06-26 | Smithkline Beecham Corporation | Ester prodrugs |
EP0358240B1 (en) * | 1985-04-19 | 1993-06-09 | Smithkline Beecham Corporation | Intermediates for the preparation of leukotriene antagonists |
US4874792A (en) * | 1985-04-19 | 1989-10-17 | Smithkline Beckman Corporation | Thiophenyl Alkanoic acids useful as leukotriene antagonists |
US4939279A (en) * | 1985-04-19 | 1990-07-03 | Smithkline Beecham Corporation | Leukotriene antagonists |
GB8530222D0 (en) * | 1985-12-07 | 1986-01-15 | Lilly Industries Ltd | Organic compounds |
US4785004A (en) * | 1985-12-23 | 1988-11-15 | Ciba-Geigy Corporation | Aromatic thioethers |
GB8709547D0 (en) * | 1987-04-22 | 1987-05-28 | Lilly Industries Ltd | Organic compounds |
GB8709546D0 (en) * | 1987-04-22 | 1987-05-28 | Lilly Industries Ltd | Pharmaceutical use of organic compounds |
US5314918A (en) * | 1987-06-24 | 1994-05-24 | Smithkline Beecham Corporation | Leukotriene antagonists |
PT87616B (pt) * | 1987-06-24 | 1992-09-30 | Smithkline Beecham Corp | Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas |
GB8725260D0 (en) * | 1987-10-28 | 1987-12-02 | Lilly Industries Ltd | Organic compounds |
AU610528B2 (en) * | 1987-10-29 | 1991-05-23 | Smithkline Beckman Corporation | Leukotriene antagonists |
GB8807016D0 (en) * | 1988-03-24 | 1988-04-27 | Lilly Industries Ltd | Organic compounds & their pharmaceutical use |
US5149717A (en) * | 1988-03-29 | 1992-09-22 | Ciba-Geigy Corporation | Alkanophenones useful for treating allergies |
DE68914225D1 (de) * | 1988-09-21 | 1994-05-05 | Searle & Co | 3-Oxiranbenzoesäuren und Derivate. |
US4954513A (en) * | 1988-12-23 | 1990-09-04 | Smithkline Beecham Corporation | Leukotriene antagonists |
US4954520A (en) * | 1989-01-19 | 1990-09-04 | G. D. Searle & Co. | 1,3-dioxolane derivatives useful in the treatment of inflammation |
EP0419410A3 (en) * | 1989-09-19 | 1991-08-14 | Ciba-Geigy Ag | Alkanophenones |
AU652776B2 (en) * | 1990-08-01 | 1994-09-08 | Smithkline Beecham Corporation | Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
MY118813A (en) * | 1997-02-12 | 2005-01-31 | Smithkline Beecham Corp | Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
US6369226B1 (en) * | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3649679A (en) * | 1968-08-15 | 1972-03-14 | Lilly Co Eli | Substituted phenylalkanoic acid derivatives ii |
GB1520812A (en) * | 1975-10-02 | 1978-08-09 | Lafon Labor | Benzhydrylsulphinyl derivatives |
US4513005A (en) * | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
CA1255329A (en) * | 1984-10-19 | 1989-06-06 | Mitsuru Tanemura | Benzoic acid derivatives |
US4755524A (en) * | 1986-01-31 | 1988-07-05 | G. D. Searle & Co. | Novel phenolic thioethers as inhibitors of 5-lipoxygenase |
-
1983
- 1983-08-03 GB GB838320943A patent/GB8320943D0/en active Pending
-
1984
- 1984-07-26 CA CA000459715A patent/CA1297632C/en not_active Expired - Fee Related
- 1984-07-30 PT PT79002A patent/PT79002B/pt not_active IP Right Cessation
- 1984-07-30 US US06/635,863 patent/US4665189A/en not_active Ceased
- 1984-07-30 NZ NZ209050A patent/NZ209050A/xx unknown
- 1984-07-30 AU AU31304/84A patent/AU575575B2/en not_active Ceased
- 1984-07-30 IL IL72539A patent/IL72539A/xx not_active IP Right Cessation
- 1984-07-31 EP EP84305203A patent/EP0134111B1/en not_active Expired
- 1984-07-31 DE DE8484305203T patent/DE3475516D1/de not_active Expired
- 1984-07-31 AT AT84305203T patent/ATE39110T1/de not_active IP Right Cessation
- 1984-07-31 GB GB08419526A patent/GB2144422B/en not_active Expired
- 1984-07-31 EP EP86106093A patent/EP0201823B1/en not_active Expired - Lifetime
- 1984-07-31 DE DE8686106093T patent/DE3483722D1/de not_active Expired - Fee Related
- 1984-07-31 AT AT86106093T patent/ATE58899T1/de active
- 1984-07-31 DK DK371384A patent/DK167008B1/da not_active IP Right Cessation
- 1984-07-31 ZA ZA845923A patent/ZA845923B/xx unknown
- 1984-07-31 PH PH31052A patent/PH21029A/en unknown
- 1984-07-31 PL PL1984249009A patent/PL144336B1/pl unknown
- 1984-08-01 FI FI843043A patent/FI81084C/fi not_active IP Right Cessation
- 1984-08-01 HU HU884449A patent/HU199457B/hu not_active IP Right Cessation
- 1984-08-01 HU HU842937A patent/HU196956B/hu not_active IP Right Cessation
- 1984-08-01 IE IE1989/84A patent/IE57691B1/en not_active IP Right Cessation
- 1984-08-01 SU SU843777634A patent/SU1402256A3/ru active
- 1984-08-01 EG EG490/84A patent/EG16349A/xx active
- 1984-08-02 ES ES534825A patent/ES534825A0/es active Granted
- 1984-08-02 KR KR1019840004617A patent/KR920005382B1/ko not_active IP Right Cessation
- 1984-08-02 JP JP59163458A patent/JPS6064954A/ja active Granted
- 1984-08-02 AR AR297435A patent/AR240796A1/es active
- 1984-08-02 GR GR80015A patent/GR80015B/el unknown
-
1987
- 1987-09-22 MY MYPI87001855A patent/MY102762A/en unknown
-
1989
- 1989-11-01 US US07/430,697 patent/USRE33300E/en not_active Expired - Lifetime
- 1989-11-01 US US07/430,105 patent/US4963578A/en not_active Expired - Lifetime
-
1990
- 1990-04-10 SG SG285/90A patent/SG28590G/en unknown
- 1990-06-05 CA CA000615758A patent/CA1301181C/en not_active Expired - Fee Related
- 1990-06-28 HK HK510/90A patent/HK51090A/xx unknown
- 1990-11-16 CY CY1539A patent/CY1539A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2144422B (en) | Novel organic compounds and their pharmaceutical use | |
PH23005A (en) | Heterocyclic compounds and pharmaceutical preparation containing the same | |
EP0138029A3 (en) | Pharmaceutical composition | |
ZA842348B (en) | Pharmaceutical compounds | |
GB2125401B (en) | Desoxyuridine derivatives and their use as pharmaceuticals | |
GR81223B (en) | Organic compounds and their pharmaceutical use | |
EG16423A (en) | Organic compounds and their pharmaceutical use | |
GB2143817B (en) | Novel pharmaceutical compounds and their preparation | |
PH22625A (en) | Benzothienylallylamines and their use as pharmaceuticals | |
ZA882517B (en) | Organic compounds and their use as pharmaceuticals | |
EP0251795A3 (en) | New compounds and their application | |
PH20528A (en) | 4-substituted-2-azetidinone compounds and medicaments containing the compounds | |
GB2151228B (en) | Organic compounds and their pharmaceutical use | |
GB2137202B (en) | Novel pharmaceutical compounds | |
GB8308414D0 (en) | Pharmaceutical composition | |
GB2181126B (en) | Novel pharmaceutical compounds | |
GB8415067D0 (en) | Medicine | |
ZA892224B (en) | Organic compounds and their pharmaceutical use | |
GB8321648D0 (en) | Pharmaceutical use | |
GB8321649D0 (en) | Pharmaceutical use | |
GB8321801D0 (en) | Pharmaceutical use | |
IL84057A0 (en) | Novel organic compounds and their preparation | |
GB8330816D0 (en) | Pharmaceutical compounds | |
GB8330817D0 (en) | Pharmaceutical compounds | |
GB8320944D0 (en) | Pharmaceutical compounds |